New Procedures to Drive Growth of $5 Billion Global Medical Aesthetic Industry
Global Aesthetic Market Study from Medical Insight, Inc. Provides Comprehensive Insights, Data and Forecasts
The 500-page GAM VI study, which is the only published report providing comprehensive and in-depth global analysis of the entire
- Skin Tightening will expand by 21.3% per year from
$79.3 millionin 2008 equipment revenues to $171.4 millionin 2012;
- Body Shaping devices will rise from
$361.9 millionin global supplier sales to $752.9 millionby 2012, for 20.1% annual growth;
- Dermal Filler sales will expand by 15.6% per year from
$822.6 millionin 2008 to $1.4 billionin 2012;
- Neuromodulators will grow by 14.8% annually from
$898.6 millionin 2008 to $1.5 billionin 2012 with the introduction of new products to compete with Botox.
“Although the aesthetic device industry contracted in 2008 due to a deepening global recession, consumer demand for cost effective treatments that address significant age-related problems represent a highly sustainable long-term market,” said
Procedure volume for all aesthetic treatments will rise by 5.6% per year from 81 million in 2008 to 101 million in 2012. During this time, total fees earned by practitioners will expand by 6.1% annually from
Public companies detailed in GAM VI include Allergan, Bioform, Candela, Cutera, Cynosure, Medicis, Mentor, Obagi, Palomar, Solta, Syneron and more than three dozen others, including the leading startup players.
For more information and to preview a table of contents and Executive Summary, visit www.miinews.com.
To download a detailed Market Forecast, go to: http://www.miinews.com/pdf/jan_feb_09/MarketForecast_TAG0109v3-020609.pdf
About Medical Insight, Inc.
Medical Insight, Inc. is the industry leader in syndicated and custom research for the aesthetic market. Under the leadership of
Contact: Michael Moretti Medical Insight, Inc. (949) 830-5409 Email: Mmoretti@MiiNews.com
SOURCE Medical Insight, Inc